• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii.

作者信息

Kimmey M B, Elmer G W, Surawicz C M, McFarland L V

机构信息

Department of Medicine, University of Washington, Seattle 98195.

出版信息

Dig Dis Sci. 1990 Jul;35(7):897-901. doi: 10.1007/BF01536805.

DOI:10.1007/BF01536805
PMID:2364845
Abstract

A patient with six documented episodes of recurrent Clostridium difficile colitis over an eight-month period is described. Relapses of colitis occurred despite treatment with vancomycin, metronidazole, bacitracin, and cholestyramine. Each recurrence appeared to begin successively closer to the end of the previous course of treatment. Four episodes were sufficiently severe to require hospitalization for rehydration. Saccharomyces boulardii, a nonpathogenic yeast, was begun prior to discontinuing vancomycin therapy for the last recurrence and was continued for three months. Serial stool cultures and assays for C. difficile showed persistence of the organism but rapid reduction of high titers of cytotoxin. No further recurrences of diarrhea or colitis were encountered while the patient was taking Saccharomyces boulardii and for 18 months of follow-up after the yeast was discontinued.

摘要

相似文献

1
Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii.
Dig Dis Sci. 1990 Jul;35(7):897-901. doi: 10.1007/BF01536805.
2
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.用万古霉素和布拉氏酵母菌治疗复发性艰难梭菌结肠炎。
Am J Gastroenterol. 1989 Oct;84(10):1285-7.
3
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.一项关于布拉氏酵母菌联合标准抗生素治疗艰难梭菌病的随机安慰剂对照试验。
JAMA. 1994;271(24):1913-8.
4
Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis.布拉酵母菌用于治疗艰难梭菌相关性结肠炎。
Ann Pharmacother. 1997 Jul-Aug;31(7-8):919-21.
5
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.布拉氏酵母菌预防抗生素相关性腹泻的前瞻性研究。
Gastroenterology. 1989 Apr;96(4):981-8. doi: 10.1016/0016-5085(89)91613-2.
6
Treatment and prevention of antibiotic associated diarrhea.抗生素相关性腹泻的治疗与预防
Int J Antimicrob Agents. 2000 Dec;16(4):521-6. doi: 10.1016/s0924-8579(00)00293-4.
7
[Recurrent Clostridium difficile enterocolitis].[复发性艰难梭菌性小肠结肠炎]
Schweiz Med Wochenschr. 2000 Nov 4;130(44):1681-4.
8
Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.布拉氏酵母菌预防艰难梭菌感染:一项系统评价
Can J Gastroenterol. 2009 Dec;23(12):817-21. doi: 10.1155/2009/915847.
9
Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis.一名患有艰难梭菌结肠炎的老年患者发生酿酒酵母菌菌血症。
Acta Clin Belg. 2004 Jul-Aug;59(4):223-4. doi: 10.1179/acb.2004.033.
10
Pseudomembranous colitis: an update.伪膜性结肠炎:最新进展
Can J Gastroenterol. 2000 Jan;14(1):51-6. doi: 10.1155/2000/324025.

引用本文的文献

1
Probiotics for the treatment of Clostridium difficile associated disease.用于治疗艰难梭菌相关性疾病的益生菌
World J Gastrointest Pathophysiol. 2013 Aug 15;4(3):47-52. doi: 10.4291/wjgp.v4.i3.47.
2
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.凝结芽孢杆菌 GBI-30, 6086 可限制万古霉素停药后小鼠艰难梭菌诱导的结肠炎复发。
Gut Pathog. 2012 Oct 22;4(1):13. doi: 10.1186/1757-4749-4-13.
3
Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.

本文引用的文献

1
Treatment of recurrent antibiotic-associated pseudomembranous colitis.
Am J Gastroenterol. 1982 Apr;77(4):220-1.
2
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.口服万古霉素治疗抗生素相关性假膜性结肠炎后的症状性复发。
Gastroenterology. 1980 Mar;78(3):431-4.
3
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.抗生素相关性结肠炎的复发:万古霉素治疗期间艰难梭菌的内源性持续存在。
凝结芽孢杆菌 GBI-30(BC30)可改善艰难梭菌诱导的结肠炎小鼠的各项指标。
Gut Pathog. 2011 Oct 20;3(1):16. doi: 10.1186/1757-4749-3-16.
4
Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.益生菌与胃肠道疾病:临床证据与基础科学
Antiinflamm Antiallergy Agents Med Chem. 2009 Sep 1;8(3):260-269. doi: 10.2174/187152309789151977.
5
Treatment of Clostridium difficile Infection.艰难梭菌感染的治疗
Curr Treat Options Gastroenterol. 2004 Jun;7(3):235-239. doi: 10.1007/s11938-004-0044-y.
6
Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans.
Dig Dis Sci. 2002 Jan;47(1):201-7. doi: 10.1023/a:1013252528691.
7
Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.布拉酵母菌刺激小鼠肠道对艰难梭菌毒素A的免疫球蛋白A免疫反应。
Infect Immun. 2001 Apr;69(4):2762-5. doi: 10.1128/IAI.69.4.2762-2765.2001.
8
Saccharomyces boulardii in maintenance treatment of Crohn's disease.布拉氏酵母菌用于克罗恩病的维持治疗
Dig Dis Sci. 2000 Jul;45(7):1462-4. doi: 10.1023/a:1005588911207.
9
Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers.健康人类志愿者体内生物治疗剂布拉酵母菌的恢复与清除
Pharm Res. 1993 Nov;10(11):1615-9. doi: 10.1023/a:1018924820333.
10
Clostridium difficile infection: a common clinical problem for the general internist.艰难梭菌感染:普通内科医生面临的常见临床问题。
J Gen Intern Med. 1994 Sep;9(9):528-33. doi: 10.1007/BF02599229.
Gut. 1983 Mar;24(3):206-12. doi: 10.1136/gut.24.3.206.
4
Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces.
Scand J Infect Dis. 1984;16(2):211-5. doi: 10.3109/00365548409087145.
5
Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.布拉氏酵母菌预防仓鼠克林霉素诱导的死亡
Antimicrob Agents Chemother. 1984 Oct;26(4):552-6. doi: 10.1128/AAC.26.4.552.
6
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.甲硝唑与万古霉素治疗艰难梭菌相关性腹泻和结肠炎的前瞻性随机试验
Lancet. 1983 Nov 5;2(8358):1043-6. doi: 10.1016/s0140-6736(83)91036-x.
7
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.抗生素相关性假膜性结肠炎多次复发患者的治疗方法
Am J Gastroenterol. 1985 Nov;80(11):867-8.
8
Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin.艰难梭菌所致抗生素相关性结肠炎:万古霉素与杆菌肽的双盲比较
Gastroenterology. 1985 Nov;89(5):1038-45. doi: 10.1016/0016-5085(85)90206-9.
9
Antibiotic-associated colitis: why do patients relapse?抗生素相关性结肠炎:患者为何会复发?
Gastroenterology. 1986 Apr;90(4):1098-9. doi: 10.1016/0016-5085(86)90914-5.
10
Rectal swab cultures for Clostridium difficile surveillance studies.用于艰难梭菌监测研究的直肠拭子培养
J Clin Microbiol. 1987 Nov;25(11):2241-2. doi: 10.1128/jcm.25.11.2241-2242.1987.